R&D investment Beijing Hanmi Pharmaceutical 2017-2022
In 2022, Beijing Hanmi Pharmaceutical's R&D investment amounted to nearly 34 billion South Korean won. This represents an increase from the previous year.
Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Chemicals and pharma consumption in Russia 2021, by segment
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Premium Statistic Chemicals and pharma export value by segment Russia 2021
- Premium Statistic Chemicals and pharma import value by segment Russia 2021
- Premium Statistic Chemicals and pharma revenue by segment Russia 2021
About the region
10
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Yuhan's net income 2015-2021
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Sales revenue distribution Yuhan 2022, by sector
Selected statistics
10
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
Other regions
10
- Premium Statistic Chemicals and pharma import value in Poland 2020-2022, by segment
- Premium Statistic Brazil: net revenue of Bayer 2013-2017
- Premium Statistic Value added of pharmaceutical companies in Italy 2016-2018
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Basic Statistic Gross profit of Sobi 2009-2022
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2022-2028
- Premium Statistic Biosimilar market size Japan 2018-2030
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic UK pharmaceutical businesses: R&D expenditure 2002-2021
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
Related statistics
10
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Yuhan-Kimberly's net profit 2016-2019
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Revenue of GC Pharma 2015-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
Further related statistics
10
- Value of chemical exports: North America 2005-2018
- Pfizer's ad spending 2008-2022
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- FMC Corporation's net income 2009-2022
- Air Liquide's market capitalization 2005-2022
- Air Liquide's total revenue 2000-2022
- Air Liquide's dividend per share 2005-2022
- Air Liquide's number of employees 2005-2022
Further Content: You might find this interesting as well
Statistics
- Value of chemical exports: North America 2005-2018
- Pfizer's ad spending 2008-2022
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- FMC Corporation's net income 2009-2022
- Air Liquide's market capitalization 2005-2022
- Air Liquide's total revenue 2000-2022
- Air Liquide's dividend per share 2005-2022
- Air Liquide's number of employees 2005-2022
Hanmi Pharmaceutical. (July 18, 2023). Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* [Graph]. In Statista. Retrieved November 28, 2023, from https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*." Chart. July 18, 2023. Statista. Accessed November 28, 2023. https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. (2023). Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)*. Statista. Statista Inc.. Accessed: November 28, 2023. https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical. "Investment in Research and Development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in Billion South Korean Won)*." Statista, Statista Inc., 18 Jul 2023, https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/
Hanmi Pharmaceutical, Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* Statista, https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/ (last visited November 28, 2023)
Investment in research and development of Beijing Hanmi Pharmaceutical Co., Ltd. from 2017 to 2022 (in billion South Korean won)* [Graph], Hanmi Pharmaceutical, July 18, 2023. [Online]. Available: https://www.statista.com/statistics/964529/beijing-hanmi-pharmaceutical-r-d-investment/